Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL (Q74213268)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2002

Language	Label	Description	Also known as
English	Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL	scientific article published on 01 May 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

stem cell transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Flohr T

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Hess G

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Kolbe K

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Gamm H

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Nolte H

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Stanislawski T

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Huber C

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Derigs HG

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

769-775

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12040475%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma. The IDEC-C2B8 Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Fukuoka Bone Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus colitis after autologous transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703515

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74213268&oldid=2220234268"